1. Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
   Tesfay M. Godefa et al, 2022, Cancers CrossRef
2. Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix
   Antonio Palumbo et al, 2020, Cells CrossRef
3. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells
   Jingxin Zhang et al, 2018, Oncology Letters CrossRef
4. Immunoexpression of galectin-3 and its potential relation to hypoxia-inducible factor-1α in ameloblastomas
   V Pereira-Prado et al, 2021, Biotechnic & Histochemistry CrossRef
5. Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
   Nadège Kindt et al, 2017, International Journal of Molecular Sciences CrossRef
6. Inhibition of galectins in cancer: Biological challenges for their clinical application
   Diego José Laderach et al, 2023, Frontiers in Immunology CrossRef
7. Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell
   Xiaobin Hou et al, 2016, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
8. Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells
   Jiaojiao Zheng et al, 2017, Oncotarget CrossRef
9. RNAi-mediated TCF-3 gene silencing inhibits proliferation of Eca-109 esophageal cancer cells by inducing apoptosis
   Jie Ma et al, 2017, Bioscience Reports CrossRef